In the news | 1st March 2017
Disruptive Technologies
PharmaVoice.com
Scott Weiss, Vice President of Product Strategy, contributes his insight to PharmaVOICE’s Disruptive Technologies issue, sharing his knowledge and thoughts on fuelling innovation and transforming the industry for the future. Read his commentary on pages 18 & 20.
More news
Ensuring product, process and patient data integrity and traceability throughout the BioPharmaceutical lifecycle in the era of personalized medicine
The BioPharma industry is facing a multitude of challenging external trends, from the growth in personalized medicine to supply chain disruptions and more.
European Biomanufacturing Summit 2023
Come and join us at booth 130 in Amsterdam, to learn how an innovative tech transfer approach can revolutionize drug manufacturing in the pharmaceutical industry.
IDBS events roundup: Q1 highlights and Q2 events
IDBS associates had the opportunity to attend some events in Q1 and attendees were eager to see, hear and learn more about what’s happening in the industry.
How to improve time-to-value using GxP computer systems
Explore the benefits of GxP computer systems to improve time-to-value so that companies can speed up the development and manufacture of life-saving drugs.